Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-26-043090
Filing Date
2026-04-13
Accepted
2026-04-13 17:25:50
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea028604803-424b3_kazia.htm 424B3 40501
2 GRAPHIC ea028604803_img1.jpg GRAPHIC 13400
  Complete submission text file 0001213900-26-043090.txt   60379
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW Australia 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-276774 | Film No.: 26858602
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)